Literature DB >> 26869677

First independent evaluation of QuantiFERON-TB Plus performance.

Lucia Barcellini1, Emanuele Borroni1, James Brown2, Enrico Brunetti3, Luigi Codecasa4, Federica Cugnata5, Paola Dal Monte6, Clelia Di Serio5, Delia Goletti7, Giulia Lombardi6, Marc Lipman2, Paola M V Rancoita5, Marina Tadolini8, Daniela M Cirillo9.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26869677     DOI： 10.1183/13993003.02033-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  30 in total

1.  QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.

Authors:  Jung-Yien Chien; Hsiu-Tzy Chiang; Min-Chi Lu; Wen-Chien Ko; Chong-Jen Yu; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 2.  Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?

Authors:  Arena Shafeque; Jacob Bigio; Catherine A Hogan; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

3.  Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.

Authors:  S A R Siegel; M Cavanaugh; J H Ku; L M Kawamura; K L Winthrop
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

4.  Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.

Authors:  Giulia Lombardi; Roberta Petrucci; Ilaria Corsini; Maria Letizia Bacchi Reggiani; Francesca Visciotti; Filippo Bernardi; Maria Paola Landini; Salvatore Cazzato; Paola Dal Monte
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

Review 5.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

6.  Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.

Authors:  Hee-Won Moon; Rajiv L Gaur; Sara Shu-Hwa Tien; Mary Spangler; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

7.  QuantiFERON-TB Performs Better in Children, Including Infants, than in Adults with Active Tuberculosis: a Multicenter Study.

Authors:  Giulia Lombardi; Maria Teresa Pellegrino; Agnese Denicolò; Ilaria Corsini; Marina Tadolini; Barbara Maria Bergamini; Marisa Meacci; Silvia Garazzino; Marta Peracchi; Marcello Lanari; Maria Carla Re; Paola Dal Monte
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

8.  Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.

Authors:  Elitza S Theel; Heather Hilgart; Margaret Breen-Lyles; Kevin McCoy; Rhiannon Flury; Laura E Breeher; John Wilson; Irene G Sia; Jennifer A Whitaker; Jeremy Clain; Timothy R Aksamit; Patricio Escalante
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

9.  QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff?

Authors:  Francesco Bisognin; Giulia Lombardi; Maria Carla Re; Paola Dal Monte
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

10.  Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study.

Authors:  Rishi K Gupta; Marc Lipman; Charlotte Jackson; Alice J Sitch; Jo Southern; Francis Drobniewski; Jonathan J Deeks; Chuen-Yan Tsou; Chris Griffiths; Jennifer Davidson; Colin Campbell; Oliver Stirrup; Mahdad Noursadeghi; Heinke Kunst; Pranab Haldar; Ajit Lalvani; Ibrahim Abubakar
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.